Thus, we investigated the impact of ZNF692 on ERK activation in osteosarcoma cells by analyzing the expression of MEK1/2, P-MEK1/2, ERK1/2, and P-ERK1/2 using Western blotting. This evidence concerns the gene MAPK1 and osteosarcoma.